INCENTIVES & VALUES PROPOSITION
Access to largest GCC market valued at US$ 5.1 billion in 2012 with over 85% of vaccines imported and health budget over SAR 50 billion.
Proximity to King Abdullah University of Science and Technology (KAUST) to facilitates the development of innovation in pharmaceutical industry with R&D centers.
CADRE providing full sponsorship to foreign employees with low labor cost with NO income tax for individuals.
Preferential government treatment for local manufacturers granted through the SFDA.
The first zone dedicated for Pharma and clean industries in Saudi and strong environmental standards.
Low energy and transportation costs.